Diamond Therapeutics Inc.
$75,000.00 CAD
≈ 12 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2023-2024
- Agreement period
- April 1, 2023 – September 30, 2024
- Reference
- nrc-cnrc:172-2023-2024-Q2-1005949
Published purpose
The project aims to develop a solid dose formulation of Diamond Therapeutic's first drug candidate for use in advanced clinical studies. Requirments for formulation development for a later stage clinical program include certain stability and other characteristics necessary for a regulatory approval and ultimately a commercial product.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions